Best Practices, LLC Home
View Cart Search the Site Contact Best Practices, LLC Press Room of Best Practices, LLC
ABOUT US RESEARCH & CONSULTING BENCHMARKING REPORTS BEST PRACTICE DATABASE RESEARCH & ADVISORY SERVICES BEST PRACTICES EXCELLENCE SERVICES
Advanced Search
Wizards and Analytics Search
Simple Search
By Subject Area
Sales and Marketing > New Product Development and Launch > Managing Thought Leader Programs > Support and Communication
Support and Communication Research

Professional Medical Education Excellence: Activities and Budget to Optimize Pharmaceutical Education Groups 
Non-members: Click here to review a complimentary excerpt from "Professional Medical Education Excellence: Activities and Budget to Optimize Pharmaceutical Education Groups" STUDY OVERVIEW The pharmaceutical sector's expanding global marketplace highlights the need for medical education groups that can adapt to new regions of the world as well as technologies for delivering programs... (ID 5149)
Companies Profiled: Abbott, Dendreon Corporation, Gilead Sciences, Epigenomics AG, more ...
Price: $3710.00   Free Excerpt Available
Professional Medical Education Excellence: Structure and Staffing to Optimize Pharmaceutical Education Groups 
Non-members: Click here to review a complimentary excerpt from "Professional Medical Education Excellence: Structure and Staffing to Optimize Pharmaceutical Education Groups" STUDY OVERVIEW Medical Education is a critical activity in the pharmaceutical sector - physicians need to be informed about new therapies that impact the treatment of their patients... (ID 5148)
Companies Profiled: Abbott, Dendreon Corporation, Gilead Sciences, Epigenomics AG, more ...
Price: $3220.00   Free Excerpt Available
Professional Medical Education Excellence: Activities and Budget to Optimize Medical Device Education Groups 
Non-members: Click here to review a complimentary excerpt from "Professional Medical Education Excellence: Activities and Budget to Optimize Medical Device Education Groups" STUDY OVERVIEW The medical device sector's expanding global marketplace highlights the need for medical education groups that can adapt to new regions of the world as well as technologies for delivering programs... (ID 5147)
Companies Profiled: Abbott, Dendreon Corporation, Gilead Sciences, Epigenomics AG, more ...
Price: $3710.00   Free Excerpt Available
Professional Medical Education Excellence: Structure and Staffing to Optimize Medical Device Education Groups 
Non-members: Click here to review a complimentary excerpt from "Professional Medical Education Excellence: Structure and Staffing to Optimize Medical Device Education Groups" STUDY OVERVIEW Medical Education is a critical activity in the medical device sector - physicians need to be trained in the safe and effective use of devices, particularly in the surgical field... (ID 5146)
Companies Profiled: Abbott, Dendreon Corporation, Gilead Sciences, Epigenomics AG, more ...
Price: $3220.00   Free Excerpt Available
Supporting Successful Product Launches: Tactics for Educating Thought Leaders 
Non-members: Click here to review a complimentary excerpt from "Supporting Successful Product Launches: Tactics for Educating Thought Leaders" Study Overview Educating the marketplace about a new product is an essential component of a successful launch and market positioning... (ID 5077)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $2610.00   Free Excerpt Available
Supporting Successful Diabetes Product Launches: Tactics for Educating Thought Leaders 
Non-members: Click here to review a complimentary excerpt from "Supporting Successful Diabetes Product Launches: Tactics for Educating Thought Leaders" Note: Data in this study are segmented to present views for Total Benchmark Class and Diabetes respondents... (ID 5071)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $2745.00   Free Excerpt Available
Onglyza Case Study: Navigating New Safety Concerns To Win Market Approval In Diabetes 
Non-members: Click here to review a complimentary excerpt from "Onglyza Case Study: Navigating New Safety Concerns to Win Market Approval in Diabetes" STUDY OVERVIEW This case study reviews the opportunities and challenges faced by Bristol-Myers Squibb and AstraZeneca at the tail end of the development of Onglyza (saxagliptin), a treatment for type 2 diabetes... (ID 5068)
Companies Profiled: AstraZeneca, Bristol-Myers Squibb
Price: $2437.00   Free Excerpt Available
Supporting Successful Oncology Product Launches: Tactics for Educating Thought Leaders 
Non-members: Click here to review a complimentary excerpt from "Supporting Successful Oncology Product Launches: Tactics for Educating Thought Leaders" Note: Data in this study are segmented to present views for Total Benchmark Class and Oncology respondents... (ID 5064)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...
Price: $2279.00   Free Excerpt Available
Januvia Case Study: Building A Blockbuster Product Franchise That Supports Brand Leadership 
Non-members: Click here to review a complimentary excerpt from "Januvia Case Study: A Blockbuster Product Franchise that Supports Brand Leadership" STUDY OVERVIEW This case study reviews the strategy and tactics utilized by Merck to build the framework that supports its blockbuster franchise Januvia, a diabetes product with a novel mechanism of action... (ID 5054)
Companies Profiled: Merck
Price: $3125.00   Free Excerpt Available
Byetta Case Study: Using Medical Education as a Springboard for Product Launch 
Non-members: To download a complimentary excerpt of this study, please click here... (ID 5007)
Companies Profiled: Amylin, Eli Lilly
Price: $4395.00   Free Excerpt Available
Rituxan Case Study: Pre-Launch Communications to Change the Dominant Treatment Paradigm 
Non-members: To download a complimentary excerpt of this study, please click here STUDY OVERVIEW This case study reviews the strategy and tactics utilized by Genentech for the Rheumatoid Arthritis (RA) indicated product, Rituxan, to communicate with KOLs regarding a new mechanism of action treatment for moderate-to-severe RA... (ID 5006)
Companies Profiled: Genentech
Price: $4995.00   Free Excerpt Available
Product Character & Position: Choosing Changes for New Growth 
Non-members: Click here to sign-up for a complimentary tour of "Product Character & Position: Choosing Changes for New Growth" Study Overview Most companies eventually must face the daunting task of re-launching a pharmaceutical product... (ID 4771)
Companies Profiled: Bayer Healthcare, UCB Pharma, Schering-Plough, Roche, more ...
Price: $1124.00
Communicating Clinical Trial Results to Physicians 
This 20-page document includes best practices and supporting graphics for communicating clinical trial results to key opinion leaders and future prescribing physicians... (ID 4430)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, AstraZeneca, Bristol-Myers Squibb, more ...
Price: $1049.95
Toolkit for Communicating Clinical Trial Results: Activities & Timing 
This document contains an introduction and 13 graphics that outline the key steps in the process of communicating clinical trial results to physicians, the managed care community and consumers... (ID 4428)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, AstraZeneca, Bristol-Myers Squibb, more ...
Price: $1499.95
Pathways to Pharmacy Relations Excellence 
Today's pharmaceutical companies recognize the importance of developing profitable and sustainable relationships with pharmacy professionals... (ID 4412)
Companies Profiled: Amgen, Wyeth, AstraZeneca, Baxter Healthcare, more ...
Price: $1124.00

 


All contents copyright © 1999-2012 Best Practices, LLC 6350 Quadrangle Drive, Chapel Hill, NC 27517 USA (919) 403-0251.
Site Map | Please see our Terms and Conditions of Use and Privacy Policy.

This site is optimized for 4.0 and higher versions of Microsoft Internet Explorer and Netscape Navigator.
If you experience difficulties using our e-commerce system, please check your browser version and our FAQs.